RxCelerate acquires UK-based molecular modeling company 07-Feb-2019 By Melissa Fassbender The outsourced drug discovery and development firm has acquired Prosarix, a UK-based molecular modeling company.
UK CRO RxCelerate sets up first US office in Boston 07-Nov-2018 By Melissa Fassbender RxCelerate is opening its first office in the US to be closer to clients and meet a "huge demand" for drug discovery and development services in the greater Boston area.